Compound details
Alfileramine
| Compound ID | CDAMM02417 |
|---|---|
| Common name | Alfileramine | IUPAC name | 4-[2-(dimethylamino)ethyl]-2-[2-[2-(dimethylamino)ethyl]-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-7-yl]phenol |
| Molecular formula | C30H42N2O2 |
| Retention time | 11.02 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 463.331 | Theoretical mz | 463.332 |
| Error | 2.11 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.2098 |
| Inchi key | GKQFYWMPBGPDAW-ZESYGTMMNA-N |
|---|---|
| Smiles | OC1=CC=C(C=C1C2C=C(C)CC3C4=CC(=CC=C4OC(C)(C)C23)CCN(C)C)CCN(C)C |
| Superclass | Organoheterocyclic compounds |
| Class | Benzopyrans |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T76685 | DI0031 | Anorexia nervosa | [ICD-11: 6B80] | P21554 | CNR1 |
| T76685 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P21554 | CNR1 |
| T76685 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P21554 | CNR1 |
| T37693 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P34972 | CNR2 |
| T37693 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P34972 | CNR2 |